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The productron and purification to protein homogeneity of a soluble form of PBP2x from a cefotaxime-resistant Streptococcusp~~eurr~on~ue strai  
is reported. It was obtained by a site-directed deletion of the membrane anchor in the corresponding gene, a method simrlar to that successfully 
utilized for the production of PBP2x from a cefotaxtme-sensrtrve weld type strain [l]. The kinetic parameters characterizmg the mteractions of both 
cefotaxime-resistant and -sensitive proteins have been determined and compared. The results are m agreement with the identification of PBP2x 
as the primary target for cefotaxtme in the sensitive strain and as probably one of several targets in the resistant strain. 
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1. INTRODUCTION 
The targets of /3-lactam antibiotics are membrane- 
bound enzymes usually called PBPs (for penicillin bind- 
ing proteins) involved in the biosynthesis and remod- 
elling of the bacterial cell wall peptidoglycan. They cat- 
alyse transpeptidation reactions which result in the 
crosslinking of the glycan chains by short peptides. Pen- 
icillin and other B-lactams inactivate these enzymes by 
acylating the active site serine residue involved in the 
transpeptidase reaction [2,3]. PBPs sometimes also con- 
tain a second domain responsible for catalysing the 
elongation of the glycan chains (transglycosylation). 
tants and natural populations is acquired by a stepwise 
alteration of the PBPs [11,13] although completely dif- 
ferent mechanisms seem to be involved [12,14]. Reduc- 
tion of p-lactam binding in four essential PBPs (1 b, 2x, 
2a and 3b) has been shown to occur in p-lactam resis- 
tant strains. In clinical isolates, the variations of the 
PBP electrophoretic patterns and the discovery of ‘mo- 
saic’ PBP gene structures reveal an extensive remod- 
elling of the penicillin binding domain of different PBPs. 
These modifications probably occurred by gene transfer 
and subsequent recombinational events. 
In both Gram-positive and Gram-negative bacteria 
intrinsic p-lactam resistance has been associated to the 
appearance of high molecular weight penicillin binding 
proteins (HMW PBPs) which exhibit a reduced ‘affinity’ 
for the p-lactam compounds [4]. 
The worldwide emergence of penicillin-resistant 
strains of Streptococcus pneumoniae is a crucial problem 
in human antibacterial therapy [5]. In this bacterium, 
alteration of target enzymes is the main mechanism re- 
sponsible for the development of penicillin resistance 
WI. 
S. pneumoniae contains five HMW PBPs (la, lb, 2x, 
2a and 2b) [9] and a LMW PBP (3) [lo]. PBP2x appears 
to be involved in the p-lactam resistance since it is the 
first PBP to be altered in cefotaxime-resistant labora- 
tory mutants [l l] and it is also modified in clinical iso- 
lates [12]. /3-Lactam resistance in both laboratory mu- 
Acquisition of /3-lactam resistance in laboratory mu- 
tants involves point mutations [15] which successively 
appear in one or several PBPs and which each contrib- 
ute to the increase of the resistance level of the strain. 
Several low-level cefotaxime-resistant variants have 
been isolated which exhibited a few amino acid substitu- 
tions in the penicillin binding domain of PBP2x [16]. 
For instance, the C604-PBP2x variant obtained after six 
selection steps displayed three amino acid substitutions 
in the penicillin binding domain (T 550 A, S 596 L and 
G 601 E). The sequences of mutational events revealed 
a complex process of resistance development since dif- 
ferent PBPs are concerned and similar levels of resis- 
tance can be acquired with totally different mutation 
patterns. 
*Corresponding author. Fax: (32) (41) 56 33 64. 
Like other HMW PBPs, PBP2x is bound to the cyto- 
plasmic membrane by a short N-terminal hydrophobic 
peptide [15]. By site-directed deletion of this membrane 
anchor, the protein was produced in a soluble form 
(called PBP2x*) and purified [l]. This derivative was 
highly soluble and stable, which greatly facilitated its 
purification and detailed study. It catalysed both the 
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hydrolysis and aminolysis of different ester and thi- 
olester substrates and the kinetic parameters character- 
istic of their interactions with /I-lactam compounds 
could easily be determined [ 171. 
In this paper. we report the production and the puri- 
fication of a soluble PBP2x derivative (PBP2x*) from 
the cefotaxime-resistant C604 mutant and a comparison 
of its kinetic parameters with those of the cefotaxime- 
sensitive R6 strain PBP2x*. We also discuss the correla- 
tion between the observed variations and the ‘minimum 
inhibitory concentration’ values. 
2. MATERIALS AND METHODS 
The pCG31 plasmid encoding PBP2x* from the R6 pemcillm-sensi- 
ttve strain was obtained by site-directed deletton of the membrane 
anchor using polymerase cham reaction technology [l]. A plasmid 
encoding a soluble form of PBP2x from the C604 mutant was con- 
structed by replacing the 1.8 kb PstI-EcoRI fragment with the corre- 
sponding fragment of the C604-PBP2x gene 
The soluble PBP2x dertvattves from the pemctllm-susceptible (R6) 
and penicillin-resistant (C604) strains were produced m E roll DH5a 
and purified according to Jamm et al. [I 71. These protems are referred 
to as R6-PBP2x* and C604-PBP2x* in the followmg text. 
Thej$lactamase from Buc11lu.t lichen{forrrtr.~ was produced and purt- 
fied as described by Matagne et al. [18]. 
Benzylpenicrllin was from Rhone-Poulenc (Paris. France), ampt- 
ctllin and oxacillin were from Bristol Benelux (Bruxelles. Belgium), 
carbenictllm. methictllin. temocillin and ticarctllm were from Beecham 
Research Laboratortes (Brentford, Middx.. UK), cefotaxtme was 
from Hoechst-Roussel (Romainville. France). cephalexin. cepha- 
loglycin and cephaloridine were from El1 L11ly and Co. (Indtanapohs. 
IN, USA). ptperactllm was from Cyanamtd and cefoxttin was from 
Merck Sharp & Dohme (Research Laboratory, Rahway, WJ. USA). 
All antibiotics were kindly given by the respecttve compames. Nitro- 
cefin was purchased from Oxotd (Basmgstoke. Hants.. UK) The 
depsipeptide substrates. hippuryl-phenyllactic actd (Sle). hippuryl- 
thtolactic acid (S3c) and benzoyl-o-alanyl-thtoglycohc acid (S2d) were 
prepared as previously described [19,20] The structures of these com- 
pounds can be found m the same articles. 
All the kinetic parameters were determmed at 37°C m IO mM 
sodium phosphate buffer pH 7.0 as described m Jamin et al. [17]. In 
brief, the hydrolysis of the substrates was directly monitored at 250 
nm, the rate of acylation by /?-lactams was determmed by followmg 
the time-dependent fluorescence decrease reflecting the accumulation 
of acyl-enzyme (I,,, = 290 nm, A,, = 340 nm) and the rate of deacyla- 
tion by recording the recovery of the enzymattc actrvity after elimma- 
tion of the excess of inacttvator by addttion of the B /&~en~firr~ris 
/I-lactamase 
The determination of the minimum inhibitory concentratton values 
(MICs) was as described in Laible et al. [I 11. The MIC value represents 
the concentration of antibtottc which is necessary to prevent vtsible 
growth starting with a sample containing 1 x 10’ cells ml-‘, thus sup- 
plying an estimate of the susceptibility of the bacterta to the antibiotic. 
3. RESULTS AND DISCUSSION 
Three direct isoforms of the C604-PBP2x* were sepa- 
rated on the Mono S column representing respectively 
25, 45 and 30% of the total protein. Each fraction 
102 
yielded a single band upon SDS-PAGE. The rates of 
acylation of the three isoforms by benzylpenicillin were 
not significantly different. indicating similar enzymatic 
properties. Such a situation had previously been found 
with the cefotaxime-sensitive R6-PBP2x”. In both cases, 
the experiments were performed with the second, most 
abundant isoform. 
The concentration of the R6-PBP2x* was determined 
by active-site titration with benzylpenicillin [17]. Unfor- 
tunately. the low activity of the C604-PBP2x* did not 
allow the utilization of this method for the modified 
enzyme. In consequence, the concentration of the C604- 
PBP2x* in the different Mono-S-fractions was esti- 
mated by fluorography after labelling with “C-ben- 
zylpenicillin. The intensity of the bands was compared 
to that obtained with a known amount of the R6- 
PBP2x* and indicated stoechiometric binding of the 
label to the protein. It could thus be considered that 
each of the isoforms was purified to homogeneity. 
Intrinsic resistance phenomena raised the intriguing 
questions of whether or not the mutations inducing al- 
terations of the pencillin-binding properties of the PBPs 
also had consequences on the efficiency of the utiliza- 
tion of the physiological substrates by these enzymes 
and if the modified PBPs were capable of fulfilling their 
role in peptidoglycan synthesis. In this respect, the hy- 
drolytic activity of the modified PBP2x* from the C604 
strain was determined vs. three substrates and the fol- 
lowing k,,,/K, values were obtained: hippuryl-phen- 
yllactic acid (Sle): k,,,/K,,, = 60 I!C 20 M-’ . s-‘, hippuryl- 
thiolactic acid (S2c): k,,,lK,,, = 350 + 100 M-’ . SC’ and 
S2a) and benzoyl-D-alanyl-thioglycolic acid (S2d): kc,,/ 
K,,, = 350 + 50 M-’ . s-l. With benzoyl-p-alanyl-thio- 
glycolic acid (S2d). aminolysis by D-alanine was also 
observed as shown by the HPLC detection of benzoyl- 
D-Ala-D-alanine. The kinetic parameters k,,,lK, for the 
hydrolysis of the thiolester substrates were thus de- 
creased about ten-fold when compared to the R6- 
PBP2x*. However, the previous studies performed with 
soluble DD-peptidases indicate that point mutations do 
not necessarily have the same consequences on the be- 
haviour of these esters and thiolesters and on that of the 
peptides which are more similar to the natural sub- 
strates [2 1.32]. Nevertheless, the enzymatic activity of 
the cefotaxime-resistant PBP was helpful for the deter- 
mination of the kinetic parameters characteristic of the 
interaction with ,&lactams. 
In a previous report, it was shown that accumulation 
of the acyl-enzyme with PBP2x* resulted in a quenching 
of the intrinsic fluorescence of the protein [ 171. A similar 
time-dependent quenching was observed with the C604- 
PBP2x* and thus. the k,lK parameters could easily be 
determined for both enzymes and with various j?-lactam 
compounds. Table I compares the values obtained with 
the R6 and C604 enzymes. The deacylation rate con- 
stants (k,) which were measured by following the recov- 
ery of the activity against benzoyl-D-alanyl-thioglycolic 
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acid (S2d) as a function of the time are shown in the 
same table. 
Intrinsic penicillin resistance phenomena are gener- 
ally attributed to a decrease of ‘affinity’ of one or sev- 
eral PBPs for p-lactams. In some cases, it has been 
demonstrated that a modification of the amounts of the 
PBPs also contributed to these phenomena [l 1.23,24]. 
According to the three step model: 
k+i kz k3 
E+Ci= EC + EC* + E + P(s) 
k-1 
a decrease of the PBP ‘affinity’ could be due to: (i) an 
increase of the dissociation constant K = k-,/k+,; (ii) a 
decrease of the first order rate constant k2; (iii) an in- 
crease of the first order rate constant k,. 
The results reported here clearly demonstrated that 
with the various p-lactams, the k, parameter was not 
affected in the modified C604 enzyme and that in conse- 
quence the decrease of penicillin binding was only due 
to the decrease of the acylation efficiency characterized 
by k,lK. It was not possible to separate the effects of the 
mutations on the individual values of k2 and K. 
The alteration of the PBP2x* sequence which de- 
creased the efficiency of acylation by cefotaxime, also 
affected the interactions with the other p-lactams. The 
mutation generally affected cephalosporins more than 
penicillins. However, acylation by a few penicillins was 
also serious impeded and the largest effect was observed 
with oxacillin. A coherent structure-activity relation- 
ship cannot be established without a knowledge of the 
tertiary structure of the enzyme. 
With other bacteria, a correlation could sometimes be 
established between the MIC values and the saturation 
of a specific PBP [2427]. In S. pneumoniue, no such 
simple relationship could be observed. With some anti- 
biotics, cell lysis could be grossly correlated with the 
partial inhibition of PBP2b [28] but the modifications 
of penicillin binding properties observed in transfor- 
mants of various resistance levels clearly indicated a 
possible implication of several or of all the HMW PBPs 
in the increased resistance [ 161. 
The comparison of the k,lK for both PBP2x* with the 
MIC values for both sensitive and low level resistant 
strains showed that: 
(1) The increased resistance of strain C604 vs. cefotax- 
ime is mainly due to a decreased affinity of this PBP for 
cefotaxime. Moreover, if PBP2x can be safely identified 
as the lethal target in the R6 strain, the MIC value for 
C604 only exhibited a 30-fold increase vs. a 300-fold 
decrease of the PBP2x* k,lK value. This indicates that 
this MIC value probably reflects the appearance of 
other PBPs as important targets in the mutant strain. 
(2) With the other /?-lactams, the situation appears to 
be more complex. The relative values of the k,lK ratios 
and of the MICs might indicate PBP2x to be also the 
target or one of the major targets of benzylpenicillin, 
oxacillin and piperacillin in the R6 strain (Table II). If 
PBP2x is the main target of a group of antibiotics, one 
would expect that a more-or-less constant value should 
be obtained when multiplying the MIC for an antibiotic 
by the corresponding k,lK value. Indeed, if the MIC is 
expressed in M, the product MIC x k,lK is a first-order 
Table I 
MIC values for the penicillin-sensitive R6 and cefotaxime-resistant C604 strains and comparison of the kinetic parameters for the interactions 
between their PBP2x and various antiblotlcs 
Antibiotics 
k21K 
(M-’ s-‘) 
R6 
k, 
(, 10: SK’) 
MIC 
@g ml-‘) 
k,lK 
(Mm’ SC’) 
C604 
k, MIC 
(, lo5 s-1) (,ug ml-‘) 
Penicillin 
Benzylpenicillin 58.000 f 5,000 5.5 2 0.5 0.01 13,200 f 3,000 5.3 * 1 0.01 
Carbemcillin 3,600 ? 100 1.5 * 0.5 ND 740 t 100 ND ND 
Ticarcillin 1,400 * 200 2.9 f 1.0 ND 87 4 5 ND ND 
Temocillm 650 + 80 ND ND 25 + 10 ND ND 
Oxaclllm 21,000 + 2.000 13 0 * 2.0 0.08 Ilk5 ND 0.08 
Plperacillin 53.000 f 3,000 0.9 + 0 5 0.02ZO 04 30.000 * 2,000 ND 0 02ZO.04 
Methiclllin 4.900 ND ND ND ND 
Carbapenem 
Imipenem 107,000 * 3,000 0.06 f 0.02 co.01 2,000 f 100 ND co.01 
Cephalosporin 
Cephalexine 1,600 + 100 2.1 + 0.5 8 13 + 3 2.6 + 1.0 8-16 
Cephaloglycm 12,400 f 3,000 4.8 f 1.0 ND 84? 10 ND ND 
Cephaloridme 93,000 + 3.000 0.18 * 0.05 ND 2,200 * 100 0 21 f 0.05 ND 
Cefotoxitine 700 + 100 0.40 f 0.10 <l 26 + 8 0.50 + 0.10 2 
Cefotaxime 162,000 + 4.000 0.10 + 0.02 0.02 510 + 30 0.17 f 0.05 0.6 
Nitrocefin 990,000 & 40,000 0.46 + 0.10 ND 5.900 2 100 ND ND 
The MIC values obtained by serial 2-fold dilutions might thus be inaccurate by a factor of 2. ND = not determined 
103 
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Table II 131 
Relationships between the MIC values for the cells and the k,lK 
parameters for PBP2x m the sensitive and resistant strains 
Antibiotics MIC x kz/K (s-l) 
R6 C604 
Benzylpenicillin 0.0018 0.0004 
Oxacilhn 0.0042 2.2 1omh 
Piperacilhn 0.0018~0.0037 0.0010~0.0021 
Cephalexin 0.0370 0.0003 
Cefotaxime 0.0071 0 0007 
141 
151 
161 
171 
181 
rate constant characteristic of the rate of acylation of 
the free PBP2x at this antibiotic concentration. If the 
value of k, is not changed and the modified PBP2x 
remains the target in the mutant, the MIC x k,lK prod- 
uct should be the same as that observed with the wild 
type. A lower value of this product indicates that an- 
other PBP must be the target of the antibiotic and thus, 
PBP9x is certainly nor the lethal target of oxacillin in the 
C604 strain. Moreover the behaviour of cephalexin 
clearly indicates that other PBPs must be involved in 
determining the MIC value. In consequence, it seems 
safe to assume that more than one HMW PBP must be 
inactivated to kill the cells but not all of them. Under 
these conditions, a PBP might appear as the ‘primary’ 
target if its inactivation is the ‘last straw’ leading to cell 
death. 
191 
1101 
1111 
11’1 
1131 
1141 
The results obtained here present the PBP2x as a 
model to study the influence of the mutations occurring 
in laboratory mutants and in clinical isolates of resistant 
strains of S. pnezunorzicze by directly measuring the inter- 
action between the protein and the ,!?-lactam com- 
pounds. It should provide a new and helpful tool for 
understanding the mechanisms responsible for intrinsic 
p-lactam resistance in this bacterial species. 
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